Publishing date: October 2020
Author(s): Joong Won Shin (1), Min Kyung Song (1), Kyung Rim Sung (2)
1 Department of Ophthalmology, College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea.
2 Department of Ophthalmology, College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea. Electronic address: firstname.lastname@example.org.
PURPOSE: To investigate whether progressive macular ganglion cell-inner plexiform layer (GCIPL) and peripapillary retinal nerve fiber layer (RNFL) thinning are predictive for detecting visual field (VF) progression in eyes with high myopia.
DESIGN: Cohort study.
METHODS: A total of 104 primary open-angle glaucoma (POAG) eyes with high myopia and 104 age- and VF severity-matched POAG eyes without high myopia (mean follow-up, 5.4 years) were included. High myopia was defined as a spherical equivalent <-6.0 diopters or axial length >26.5 mm. Progressive GCIPL, RNFL, and VF deterioration were determined by Guided Progression Analysis (GPA) in optical coherence tomography and standard automated perimetry. The risk of VF progression was evaluated using Cox proportional hazard models.
RESULTS: Highly myopic eyes with progressive GCIPL thinning had a significantly higher risk of developing VF progression after adjusting for the baseline intraocular pressure (HR, 4.00; P = 0.001) or peak intraocular pressure (HR, 3.11; P = 0.011) in the multivariable Cox proportional hazard model, whereas highly myopic eyes with progressive RNFL thinning were not significantly associated with VF progression. In eyes without high myopia, both progressive GCIPL (HRs, 4.67 or 3.62; P = 0.008 or 0.037, respectively) and RNFL (HRs, 6.60 or 3.97; P = 0.001 or 0.016, respectively) thinning were associated with a significantly higher risk of developing VF progression after adjusting for the baseline or peak intraocular pressure .
CONCLUSIONS: Monitoring macular GCIPL thickness was effective for predicting glaucoma progression regardless of the presence of high myopia.
Copyright © 2020 Elsevier Inc. All rights reserved.
Am J Ophthalmol. 2020 Sep 29;S0002-9394(20)30548-1.
Clinical Paper of the Month manager: Marta Pazos